Taro Pharmaceutical Industries (NYSE:TARO – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued on Tuesday. Separately, TheStreet raised shares of Taro Pharmaceutical Industries from a “d+” rating to a “c-” rating in a report on Monday, June 26th. Read […]
Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Free Report) saw an uptick in trading volume on Wednesday . 28,382 shares traded hands during mid-day trading, a decline of 16% from the previous session’s volume of 33,622 shares.The stock last traded at $37.93 and had previously closed at $37.12. Wall Street Analysts Forecast Growth A number […]
StockNews.com lowered shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Saturday morning. Separately, TheStreet raised Taro Pharmaceutical Industries from a d+ rating to a c- rating in a research report on Monday, June 26th. Get Our Latest Analysis […]
Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Free Report) saw strong trading volume on Monday . 101,583 shares traded hands during trading, an increase of 201% from the previous session’s volume of 33,753 shares.The stock last traded at $38.66 and had previously closed at $38.00. Analysts Set New Price Targets A number of equities analysts […]
StockNews.com downgraded shares of Taro Pharmaceutical Industries (NYSE:TARO – Get Rating) from a strong-buy rating to a buy rating in a research note released on Thursday. Taro Pharmaceutical Industries Stock Up 1.2 % Taro Pharmaceutical Industries stock opened at $38.77 on Thursday. Taro Pharmaceutical Industries has a 52-week low of $22.89 and a 52-week high […]